Acquisitions, Divestitures, Equity-Method Investments, Collaborative Arrangements, Research and Development Arrangements and In-Licensing Arrangements - Pro Forma Information (Details) - Seagen [Member] - USD ($) $ / shares in Units, $ in Millions |
1 Months Ended | 12 Months Ended |
|---|---|---|
Dec. 31, 2023 |
Dec. 31, 2023 |
|
| Business Combination [Line Items] | ||
| Revenues | $ 132 | |
| Net loss attributable to Pfizer Inc. common shareholders | $ (746) | |
| Revenues | $ 61,893 | |
| Net income/(loss) attributable to Pfizer Inc. common shareholders | $ (1,481) | |
| Diluted earnings/(loss) per share attributable to Pfizer Inc. common shareholders | $ (0.26) |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per diluted share amount, after tax, of pro forma income (loss) of combined entity as if acquisition date of business combination occurred as of beginning of period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, after tax, of pro forma income (loss) of combined entity as if acquisition date of business combination occurred as of beginning of period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of pro forma revenue of combined entity as if acquisition date of business combination occurred as of beginning of period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of acquiree's earnings (loss) since acquisition date of business combination included in consolidated statement of income. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of acquiree's revenue since acquisition date of business combination included in consolidated statement of income. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|